MUKKA NSE filing

Mukka Proteins receives ₹7.82 crore GST demand notice for alleged ineligible IPO-related ITC

The RealCase readMedium impact Negative

Why it matters

While the demand is substantial at ₹7.82 crore, the company asserts that the demand is not maintainable and does not anticipate any relevant impact on its financials or operations, indicating a potential legal challenge rather than an immediate financial hit.

The market read

The company has received GST demand notices totaling ₹7.82 crore, including tax, interest, and penalty, which represents a significant financial claim against the company.

Mukka Proteins Limited received two Goods & Services Tax (GST) notices from The Joint Director, Directorate General of Goods & Services Tax Intelligence, Belagavi Zonal Unit, on 25 August 2025. * The notices allege ineligible availment of Input Tax Credit (ITC) on services availed in connection with the company's Initial Public Offering (IPO). * The alleged ineligible ITC pertains to: * FY 2021-22 to 2023-24, with a demand of ₹4,36,78,720 (approximately ₹4.37 crore). * FY 2024-25, with a demand of ₹3,44,89,344 (approximately ₹3.45 crore). * The total tax, interest, and penalty aggregated to ₹7,81,68,064 (approximately ₹7.82 crore). * The authority has indicated that such expenses relate to the issue of shares, which is considered a non-GST supply, and has advised payment or submission of a representation by 27 August 2025. * Mukka Proteins Limited is in the process of examining the matter and believes the demand is not maintainable, evaluating all options including filing an appeal against the demand. * The company does not envisage any relevant impact on its financials, operations, or other activities.

Filing to action

What to do with a filing like this

Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under regulatory filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.

View original filing